FACTX Holdings Information

FACTX is a mutual fund with a total of 134 individual holdings. The top holdings are Eli Lilly and Company stock at 6.63%, Danaher at 6.57%, Johnson & Johnson at 5.91%, Boston Scientific at 5.08%, and AbbVie at 3.62%.

Total Holdings

134

Top 10 Percentage

40.27%

Asset Class

Equity

Fund Category

Health

Assets

2.89B

Forward PE Ratio

21.61

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	6.63%	210,000
2	DHR	Danaher Corporation	6.57%	1,010,000
3	JNJ	Johnson & Johnson	5.91%	705,000
4	BSX	Boston Scientific Corporation	5.08%	2,360,000
5	ABBV	AbbVie Inc.	3.62%	485,000
6	ASND	Ascendis Pharma A/S	2.78%	354,000
7	GILD	Gilead Sciences, Inc.	2.58%	540,000
8	EBR: UCB	UCB SA	2.53%	245,000
9	MRK	Merck & Co., Inc.	2.48%	600,000
10	EW	Edwards Lifesciences Corporation	2.09%	760,000
11	ARGX	argenx SE	1.95%	78,000
12	ALNY	Alnylam Pharmaceuticals, Inc.	1.90%	167,000
13	TMO	Thermo Fisher Scientific Inc.	1.82%	108,000
14	INSM	Insmed Incorporated	1.60%	285,000
15	COR	Cencora, Inc.	1.55%	143,500
16	COGT	Cogent Biosciences, Inc.	1.51%	1,140,000
17	BTSG	BrightSpring Health Services, Inc.	1.46%	1,000,000
18	NUVL	Nuvalent, Inc.	1.29%	368,000
19	UNH	UnitedHealth Group Incorporated	1.25%	135,000
20	MCK	McKesson Corporation	1.25%	42,000
21	MRNA	Moderna, Inc.	1.22%	700,000
22	XENE	Xenon Pharmaceuticals Inc.	1.20%	600,000
23	CNTA	Centessa Pharmaceuticals plc	1.16%	850,000
24	CVS	CVS Health Corporation	1.15%	468,000
25	CAI	Caris Life Sciences, Inc.	1.02%	1,670,000

Showing 25 of 134 holdings

Subscribe to see the full list

Activate Now

As of Mar 31, 2026